Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the feasibility of a 60 minute rapid infusion
rituximab protocol in the institution's outpatient infusion center.